| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jun Lu | |
| Yizhi Wang | |||
| Junchao Guo | |||
| Bolun Jiang | |||
| P2860 | cites work | Adoptive cell transfer: a clinical path to effective cancer immunotherapy | Q24644774 |
| Cancer immunoediting from immune surveillance to immune escape | Q24655415 | ||
| Application of IL-2 therapy to target T regulatory cell function | Q26827327 | ||
| Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT | Q28115618 | ||
| M-1/M-2 macrophages and the Th1/Th2 paradigm | Q28145893 | ||
| Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 | ||
| Interferons, immunity and cancer immunoediting | Q28270336 | ||
| Apoptosis: a review of programmed cell death | Q28305845 | ||
| Turmeric and curcumin as topical agents in cancer therapy | Q28337835 | ||
| MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN | Q29616575 | ||
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
| Immunosuppressive strategies that are mediated by tumor cells | Q29636247 | ||
| Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. | Q31775425 | ||
| Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy | Q33282319 | ||
| Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell | Q33751048 | ||
| Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts | Q34105756 | ||
| Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells | Q90448139 | ||
| Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression | Q90683248 | ||
| Curcumin as a Therapeutic Strategy in Liver Diseases | Q90802894 | ||
| Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells | Q90840787 | ||
| A Curcumin Analog Reduces Levels of the Alzheimer's Disease-Associated Amyloid-β Protein by Modulating AβPP Processing and Autophagy | Q90877058 | ||
| Cancer statistics, 2019 | Q90941571 | ||
| Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy | Q90955067 | ||
| Induction Apoptosis of Erinacine A in Human Colorectal Cancer Cells Involving the Expression of TNFR, Fas, and Fas Ligand via the JNK/p300/p50 Signaling Pathway With Histone Acetylation | Q91081530 | ||
| Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma | Q91083865 | ||
| Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment | Q91133917 | ||
| Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer | Q91154729 | ||
| Curcumin Elevates TFH Cells and Germinal Center B Cell Response for Antibody Production in Mice | Q91261675 | ||
| Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications | Q91835845 | ||
| The immunomodulatory potential of natural compounds in tumor-bearing mice and humans | Q91839819 | ||
| Recent advances of analogues of curcumin for treatment of cancer | Q92124700 | ||
| Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue? | Q92165104 | ||
| Curcumin exerts cytotoxicity dependent on reactive oxygen species accumulation in non-small-cell lung cancer cells | Q92185177 | ||
| Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression | Q92259148 | ||
| The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective | Q92307792 | ||
| Neoantigen-directed immune escape in lung cancer evolution | Q92512819 | ||
| JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer | Q92575584 | ||
| Modulation of regulatory T cells by natural products in cancer | Q92605097 | ||
| Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway | Q92664494 | ||
| The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function | Q92713792 | ||
| FGF14 Functions as a Tumor Suppressor through Inhibiting PI3K/AKT/mTOR Pathway in Colorectal Cancer | Q92713830 | ||
| Fas Ligand Enhances Apoptosis of Human Lung Cancer Cells Cotreated with RIG-I-Like Receptor Agonist and Radiation | Q92726229 | ||
| Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle | Q92744972 | ||
| Advances in molecular classification and precision oncology in hepatocellular carcinoma | Q92746879 | ||
| Curcumin inhibits the growth via Wnt/β-catenin pathway in non-small-cell lung cancer cells | Q93367877 | ||
| Non-Smad TGF-beta signals | Q34443708 | ||
| Multiple biological activities of curcumin: a short review | Q34564204 | ||
| Immune surveillance of tumors | Q34579196 | ||
| Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases | Q34594807 | ||
| Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients | Q34652865 | ||
| Phase II trial of curcumin in patients with advanced pancreatic cancer | Q34796370 | ||
| Molecular mechanisms and biological significance of CTL avidity | Q35716722 | ||
| Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. | Q35876385 | ||
| Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer | Q36544511 | ||
| Curcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model. | Q36756833 | ||
| Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response. | Q36881910 | ||
| Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity | Q36959191 | ||
| Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Q37163664 | ||
| Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1. | Q37236288 | ||
| Anti cancer effects of curcumin: cycle of life and death | Q37286351 | ||
| Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines | Q37356349 | ||
| Development of adoptive cell therapy for cancer: a clinical perspective. | Q37735196 | ||
| The biology of cancer testis antigens: putative function, regulation and therapeutic potential | Q37849976 | ||
| Death by design: where curcumin sensitizes drug-resistant tumours | Q38023357 | ||
| Molecular mechanisms of curcumin action: signal transduction | Q38072888 | ||
| Trop2: from development to disease | Q38293559 | ||
| Immune evasion in cancer: Mechanistic basis and therapeutic strategies. | Q38394302 | ||
| GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells | Q38496048 | ||
| Healthcare cost of HER2-positive and negative breast tumors in the United States (2012-2035). | Q38597755 | ||
| Curcumin converts Foxp3+ regulatory T cells to T helper 1 cells in patients with lung cancer. | Q38668305 | ||
| Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer | Q38717405 | ||
| Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway | Q38749325 | ||
| Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions | Q38795793 | ||
| Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway | Q38853976 | ||
| Hepatic stellate cell interferes with NK cell regulation of fibrogenesis via curcumin induced senescence of hepatic stellate cell | Q38966202 | ||
| Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy. | Q38988078 | ||
| Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression | Q39268767 | ||
| Epigenetics and immunotherapy: The current state of play | Q39311485 | ||
| Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity | Q39557788 | ||
| Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways | Q40000365 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study | Q40103479 | ||
| Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. | Q40185330 | ||
| Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. | Q40452646 | ||
| Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment | Q40926199 | ||
| Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production | Q40955488 | ||
| Curcumin reduces mitomycin C resistance in breast cancer stem cells by regulating Bcl-2 family-mediated apoptosis | Q41670781 | ||
| Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells | Q41786461 | ||
| Curcumin up regulates T helper 1 cells in patients with colon cancer | Q42146463 | ||
| Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer | Q42382997 | ||
| IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence | Q42698829 | ||
| Low Doses of Curcuma longa Modulates Cell Migration and Cell-Cell Adhesion | Q42798467 | ||
| Curcumin and gemcitabine in patients with advanced pancreatic cancer | Q42832062 | ||
| Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability | Q44120619 | ||
| Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008. | Q44793977 | ||
| Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival. | Q46008329 | ||
| Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going | Q47123105 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| Curcumin downregulates the expression of Snail via suppressing Smad2 pathway to inhibit TGF-β1-induced epithelial-mesenchymal transitions in hepatoma cells | Q47220613 | ||
| Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement | Q47382189 | ||
| Direct regulation of IL-2 by curcumin | Q47415221 | ||
| Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells | Q47854040 | ||
| Vascular endothelial growth factor: An important molecular target of curcumin | Q48155329 | ||
| TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors. | Q49911093 | ||
| The mismatch repair gene hPMS1 (human postmeiotic segregation1) is down regulated in oral squamous cell carcinoma. | Q51052218 | ||
| Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation. | Q51175296 | ||
| Improved anti-cancer effect of curcumin on breast cancer cells by increasing the activity of natural killer cells. | Q52593782 | ||
| Cytokine-mediated therapeutic resistance in breast cancer. | Q53699336 | ||
| Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells. | Q55380170 | ||
| Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells | Q57167122 | ||
| Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial | Q58487847 | ||
| Cancer immunoediting and resistance to T cell-based immunotherapy | Q60489257 | ||
| Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells | Q60489570 | ||
| Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer | Q60916351 | ||
| Curcumin inhibits the proliferation and invasion of MG-63 cells through inactivation of the p-JAK2/p-STAT3 pathway | Q64089671 | ||
| An ingenious non-spherical mesoporous silica nanoparticle cargo with curcumin induces mitochondria-mediated apoptosis in breast cancer (MCF-7) cells | Q64265785 | ||
| The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent | Q73565556 | ||
| Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery | Q78900687 | ||
| Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice | Q82772904 | ||
| A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer | Q85064815 | ||
| Curcumin and dietary polyphenol research: beyond drug discovery | Q88064814 | ||
| Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells | Q89341436 | ||
| Curcumin inhibits proliferation and enhances apoptosis in A549 cells by downregulating lncRNA UCA1 | Q90003681 | ||
| Trends and Challenges in Tumor Anti-Angiogenic Therapies | Q90194802 | ||
| Curcumin and arterial function in health and disease: impact on oxidative stress and inflammation | Q90436986 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 3059-3070 | |
| P577 | publication date | 2020-03-03 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | The roles of curcumin in regulating the tumor immunosuppressive microenvironment | |
| P478 | volume | 19 |
Search more.